Cyxone in media

Cyxone in media

Pharmaceutical Business Review: Cyxone MS drug T20K succeeds in preclinical program

Nov 29, 2018

Cyxone MS drug T20K succeeds in preclinical program Cyxone said that T20K, its investigational drug for the treatment of multiple sclerosis (MS), has succeeded in a preclinical program by yielding positive results in the toxicology studies. According to Cyxone,...

Read More

MedUni Vienna technology wins Recognition Prize in the science2business awards

May 24, 2017

A joint project between MedUni Vienna and Freiburg University Hospital, using cyclotides as a treatment for multiple sclerosis, was awarded the Recognition Prize in the science2business awards. This development is an example of a successful transfer of innovation from...

Read More

Multiple sclerosis: plant peptide could prevent onset of the disease

Jun 17, 2016

MedUni Vienna has made a crucial development in the treatment of Multiple Sclerosis (MS): Together with his team and the research group led by Gernot Schabbauer, international partners from Australia, Germany and Sweden, Christian Gruber, Chief Researcher at the...

Read More

Successful IPO with MedUni Vienna patent

Jun 17, 2016

Swedish company Cyxone, a subsidiary of ACCEQUA AB, headquartered in Malmö, recently went public – on the basis of a MedUni Vienna patent application relating to the potential development of an oral medication to combat multiple sclerosis. The invention...

Read More

Multiple sclerosis: Plant peptide could prevent onset of the disease

Apr 18, 2016

https://www.sciencedaily.com/releases/2016/03/160329101244.htm

Read More

Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis

Apr 18, 2016

http://www.pnas.org/content/113/15/3960.full

Read More

Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis

Apr 4, 2016

http://www.pnas.org/content/early/2016/03/22/1519960113.full.pdf http://tvthek.orf.at/program/ZIB-1/1203/ZIB-1/12317916/Hoffnung-fuer-Multiple-Sklerose-Patienten/12318077

Read More